Technology
Health
Biotechnology

Soligenix

956

$1.58
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-1.86%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Soligenix and other stocks, options, ETFs, and crypto commission-free!

About SNGX

Soligenix, Inc. engages in the development and commercialization of products to treat rare disease. It operates through the following segments: BioTherapeutics and Vaccines/BioDefense. Read More The BioTherapeutics segment offers photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Vaccines/BioDefense segment includes active development programs for RiVax, ricin toxin vaccine candidate, OrbeShield, GI acute radiation syndrome therapeutic candidate, and SGX943, melioidosis therapeutic candidate. The company was founded in 1987 and is headquartered Princeton, NJ.

CEO
Christopher J. Schaber
Employees
14
Headquarters
Princeton, New Jersey
Founded
1987
Market Cap
35.52M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
797.17K
High Today
$1.63
Low Today
$1.40
Open Price
$1.60
Volume
391.81K
52 Week High
$3.54
52 Week Low
$0.65

Collections

Technology
Health
Biotechnology
Therapy
2016 IPO
US
North America

SNGX Earnings

-$0.18
-$0.12
-$0.06
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Apr 13, Pre-Market

People Also Bought

Agile Therapeutics

20,012

$1.90

-5.47%

Agile Therapeutics

20,012

$1.90

-5.47%

Onconova Therapeutics

26,200

$0.3101

-3.96%

Titan Pharmaceuticals

35,609

$0.265

+3.72%

Oragenics

52,483

$0.57

+4.68%

You May Also Like

FAUG
IMH
SIX
ICCC
AEMD
JPHF
MBUU
EGRX
TWIN
ILF
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy SNGX

Market Price$1.58
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Soligenix stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up